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The alternative pathway of complement is an impor-
tant defense against pathogens and in tick rejection
reactions. The tick Ixodes scapularis is able to feed re-
peatedly on its natural host and has a salivary anticom-
plement activity that presumably facilitates feeding. In
this study, we purified and then obtained the amino-
terminal sequence of the I. scapularis salivary anticom-
plement (Isac). We found a full-length clone coding for
Isac by random screening of a salivary gland cDNA li-
brary. Expressing Isac cDNA in COS cells reproduced
the activity found in tick saliva, namely, inhibition of
rabbit erythrocyte lysis by human serum in the presence
of Mg21 and EGTA, inhibition of C3b binding to agarose
in the presence of Mg21 and EGTA, and acceleration of
factor Bb uncoupling from the C3 convertase generated
by the alternative pathway. Recombinant Isac had no
effect on the recalcification time of human platelet-poor
plasma or in the classical complement pathway, indicat-
ing that it is a specific inhibitor similar to the regulators
of complement activation of the alternative pathway
such as factor H. Isac, however, has no similarity to any
protein in the GenBankTM data base, indicating that it is
a novel and relatively small (18.5 kDa) anticomplement
molecule.
The alternative pathway of complement is an evolutionarily
old first line of defense against pathogens (1). Complement
activation leads to the production of inflammatory anaphyla-
toxins (2, 3) and to the formation of a membrane attack com-
plex leading to the lysis of the invading organism (1). Endoge-
nous regulators exist to prevent pathology associated with
unconfined or inadvertent complement activation (4, 5). Suc-
cessful pathogens have developed several mechanisms to evade
the host complement system (1, 6, 7). In several of these eva-
sion mechanisms, pathogens may recruit host complement reg-
ulatory molecules to their own surface or produce inhibitors of
complement activation, which are either secreted or remain
associated with their surfaces (1, 6–8).
Ticks are ectoparasites that may feed for several days or
even weeks with their mouth parts embedded into their verte-
brate hosts. Although unnatural hosts can mount an effective
immune response against ticks (9, 10), only minor rejection
reactions are observed when ticks feed on their natural hosts
(9, 11). The alternative pathway of complement was implicated
in rejection reactions of guinea pigs against the tick Dermacen-
tor andersoni (12, 13). The tick vector of Lyme disease in
Eastern North America, Ixodes scapularis, can successfully
feed repeatedly on its natural host, the white-footed mouse,
Peromyscus leucopus (9, 14), perhaps because it has salivary
compounds that deactivate anaphylatoxins (15) and inhibit the
alternative pathway of complement (16). Indeed, the host range
of Ixodes correlates with their ability to counteract the alter-
native complement pathway of their most common hosts (17).
I. scapularis saliva has an inhibitor of the alternative path-
way of complement activation (16), as shown by inhibition of
the lysis of rabbit erythrocytes by human sera in the presence
of EGTA and Mg21 ions. This saliva also prevents deposition of
C31 to agarose-coated plates and inhibits release of C3a by the
C3 convertase formed by the alternative pathway of comple-
ment activation (16). Because the molecular nature of this
inhibitor remained unknown, we purified, obtained an amino-
terminal sequence, cloned, and expressed Isac, which is a novel
molecule behaving as a regulator of complement activation.
Isac is one of the smallest proteins known to have regulator of
complement activation activity and may serve as a tool to
understand C3 convertase regulation.
MATERIALS AND METHODS
Ticks—Tick saliva was obtained by inducing partially engorged adult
female I. scapularis to salivate into capillary tubes using the pilo-
carpine induction method (18). Briefly, ticks engorging for 4–5 days on
the ears of New Zealand White rabbits were harvested, rinsed in dis-
tilled water, and fixed to glass microscope slides with double-sided tape.
A sterile glass micropipette was placed around the tick hypostome to
collect saliva. Salivation was induced by applying 2 ml of pilocarpine (50
mg/ml in 95% ethanol) to the scutum of the tick. Ticks were incubated
at 35 °C in a humid chamber until salivation ceased (2–3 h). Volumes
ranged from 2.5 to 10 ml/tick. Tick salivary gland extracts were pre-
pared by collecting glands from partially engorged female I. scapularis
as described. Glands were dissected by first bisecting the tick and then
teasing the salivary glands away from the other internal organs and the
tick exoskeleton. Glands were rinsed by immersion in HEPES-saline
buffer (10 mM HEPES, pH 7.0, 150 mM NaCl) and stored frozen at
275 °C until needed.
Reagents—Water was purified with a Milli-Q system from Millipore
(Bedford, MA). Organic reagents were obtained from Sigma. Goat anti-
human C3 antibody (catalog no. C-7761) was from Sigma. Goat anti-
human factor B (catalog no. 31-785) was from Nordic Immunology
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(Tiburg, Netherlands). Rabbit anti-goat IgG, peroxidase conjugated and
adsorbed against other human serum proteins (catalog no. A-4174, lot
78H9200), and anti-sheep erythrocyte stroma sera (part no. S 1389)
were from Sigma. Agarose (ultraPure; Life Technologies, Inc.) was used
to coat Immulon I microplates (Dynatech Laboratories, Inc., Alexan-
dria, VA).
Erythrocyte Lysis Assays—To test for the alternative pathway of
complement activation using rabbit erythrocytes and human serum
(19), rabbit erythrocytes in Alsever’s solution (Spring Valley Labs,
Woodbine, MD) were washed five times with 10 vol of 150 mM NaCl, 10
mM HEPES, pH 7.4 (HEPES saline), followed by centrifugation for 2 s
at 10,000 3 g. Reaction medium, in a 96-well plate, contained 0.4%
packed erythrocytes in 40 ml of 6.25 mM EGTA, 2.5 mM MgCl2, 20 mM
HEPES, pH 7.4, and 150 mM NaCl. Additionally, 5 ml of the test sample
or HEPES saline control was added. In some cases, a larger amount of
test sample was added, with corresponding changes in the buffer ali-
quot to keep the same concentrations of buffers, divalent cations, and
chelators. A reaction was started with the addition of 5 ml of human
serum. Control reactions were run in which 12.5 mM EDTA was sub-
stituted for EGTA and MgCl2. The plate was added to a Thermomax
plate reader (Molecular Devices, Menlo Park, CA) set at 37 °C and was
monitored at both 405 and 650 nm. The resulting value representing
[A405 2 (A650 3 1.5)] was plotted, and the time to achieve one-half of
maximal lysis was determined from the curve. Whereas the absorbance
at 405 nm reflects the hemoglobin released by the cells, the absorbance
at 650 nm controls for the turbidity change in the microwells. The value
of 1.5 corrects for the decreased light scattering at the larger wave-
length. In some cases, end point assays were done, and the value
representing the absorbance at 405 nm corrected for turbidity as above
being taken as a measure of erythrocyte lysis.
Assays to measure classical pathway lysis of sheep erythrocytes
using anti-sheep erythrocyte antibody followed manufacturer’s instruc-
tions (Sigma). Briefly, washed sheep erythrocytes (50 ml of packed
erythrocytes/ml) were incubated with 1:100 dilution of the sera for 20
min at 37 °C and stored at 4 °C until needed. The remainder of the
assay was identical to that described above to detect alternative pathway-
dependent lysis of rabbit erythrocytes as described above, except that 2
mM CaCl2 was used instead of EGTA.
Enzyme-linked Immunosorbent Assays for Measuring C3 and Factor
B (fB)—To more specifically identify inhibitory activity within the com-
plement cascade, we measured complement deposition to agarose-
coated wells in 96-well plates. Agarose activates the alternative path-
way of complement (20). Plates were pretreated with 100 ml of 0.1%
agarose in water (melted by boiling and kept at 50 °C) and incubated at
37 °C for 48 h, when dry. Wells were then incubated with 50 ml of 20 mM
HEPES, pH 7.4, 150 mM NaCl, 5 mM EGTA, 2 mM MgCl2, and 10%
human serum, containing 5 ml of the test solution or HEPES saline.
Control wells were run without serum or agarose coating, or 10 mM
EDTA was substituted for MgCl2 and EGTA. We chose to use the EDTA
method as a routine blank for these assays. To reveal C3 or fB binding
to the plate, plates were washed five times (for 3 min each washing,
with slow orbital shaking of the plate) with 200 ml of HEPES saline
containing 2 mM MgCl2 and 10 mg/ml bovine serum albumin, followed
by the addition of 100 ml of a 1:5000 dilution of the anti-C3 or 1:250
dilution of the anti-fB antibody. These were incubated for 1 h at 37 °C,
washed five times as before, and the anti-goat peroxidase conjugate was
added at 1:5000 dilution. Following incubation for 1 h at 37 °C, the
conjugate was washed twice each with HEPES saline containing 10
mg/ml bovine serum albumin, then 0.1% Tween 20, then normal saline.
Peroxidase activity was detected by adding a solution of HEPES saline
containing 1 mg/ml orthophenylene-diamine (previously diluted in
methanol to give 100 mg/ml) and 8.8 mM hydrogen peroxide. The rate of
increase in absorption at 405 nm was measured in a Thermomax
(Thermo Separation Products, Rivera Beach, FL) plate reader.
Human Plasma Recalcification Assay—To measure recalcification
time of human plasma, 30 ml of human citrated plasma (0.38% final
citrate concentration) was mixed with equal volumes of either test
samples or HEPES saline in a 96-well plate. Reactions were initiated by
adding 30 ml of 25 mM CaCl2 to each mixture. The increase in turbidity
at 650 nm was monitored in a Thermomax plate reader (Thermo Sep-
aration Products). Clotting time was determined as the time to reach
0.025 absorption units.
High Performance Liquid Chromatography (HPLC) Procedures—
Thermomax (Thermo Separation Products, Riviera Beach, FL) CM4000
or CM4100 pump was used in conjunction with a dual wavelength
UV-visible detector model SM4100 from the same company. Molecular
sieving chromatography used a TSK-SW 2000 column (1 x 80 cm for
purification purpose or 0.43 3 25 cm for analytical purpose) (TosoHass,
Montgomeryville, PA), eluted with 10 mM HEPES, pH 7.0, 150 mM NaCl
at the specified flow rates. Reverse-phase chromatography used one or
two PRP infinity columns linked in tandem and eluted at 0.5 ml/min
with the indicated gradients of acetonitrile in 8 mM HCl or trifluoro-
acetic acid. HCl, as a modifier in reverse-phase chromatography, pro-
tonates and neutralizes the negatively charged protein carboxyl groups,
thus increasing their hydrophobicity, but fails to form significant ion
pairs of the positively charged amino groups with the chloride anion.
Trifluoroacetic acid similarly causes protein protonation, but the anion
forms significant ion pairs with the positively charged amino groups,
and these ion pairs have increased hydrophobicity and consequent
increased retention time. As a result, when a peptide mixture is run in
reverse-phase using HCl and trifluoroacetic acid consecutively, the
order of peptide elution may change according to the differences in the
charge of basic residues. Because trifluoroacetic acid elution gives rise
to sharper peaks, it is best that HCl elution is done first followed by
trifluoroacetic acid elution, where the peaks are most concentrated.
Silica-based octadecyl columns lead to complete loss of anticomplement
activity. Fractions of the reverse-phase columns were dried in a Speed-
Vac-SC 110 (Savant Instruments, Inc., Holbrook, NY) in the presence of
10 mg of bovine serum albumin (in 10 ml of water) to prevent irreversible
protein adsorption to the walls of the plastic tubes. Dried samples were
resuspended in buffer.
Edman Degradation—Amino-terminal sequencing of the HPLC-pu-
rified proteins was performed at the Harvard microsequencing facility
under the direction of Dr. William Lane.
Salivary Gland cDNA Library Construction—I. scapularis salivary
gland mRNA was isolated from 25 pairs of salivary glands dissected
from adult female ticks feeding for 3–4 days on a rabbit. We used the
Micro-FastTrack mRNA isolation kit (Invitrogen, San Diego, CA),
which yielded a total of 200 ng of poly(A)1 mRNA. The polymerase
chain reaction (PCR)-based cDNA library was made following the in-
structions for the SMART cDNA library construction kit (CLONTECH,
Palo Alto, CA). The I. scapularis salivary gland mRNA (200 ng) was
reverse-transcribed to cDNA for 1 h at 42 °C using Superscript II RNase
H– reverse transcriptase (Life Technologies, Inc.) and the CDS/39-
primer (CLONTECH). Second strand synthesis was performed using a
PCR-based protocol with the SMART III primer (CLONTECH) as the
sense primer and the CDS/39-primer as antisense primer; these two
primers contain, at the ends of the nascent cDNA, SfiI A and B sites,
respectively. For double-stranded cDNA synthesis, we used a 9700
Thermalcycler (Perkin-Elmer Corp.) and Advantage Klen-Taq DNA
polymerase (CLONTECH). PCR conditions were: 94 °C for 2 min; 18
cycles of 94 °C for 10 s, and 68 °C for 6 min. Double-stranded cDNA was
immediately treated with proteinase K (0.8 mg/ml) for 20 min at 45 °C
and washed three times with water using Amicon filters with a 100-kDa
cut-off (Millipore Corp.). The double-stranded cDNA was digested with
SfiI for 2 h at 50 °C and then fractionated using columns provided by
the manufacturer (CLONTECH). Fractions containing cDNA of more
than 400 base pairs were pooled, concentrated, and washed three times
with water using an Amicon filter with a 100-kDa cut-off. The cDNA
was concentrated to a final volume of 7 ml. The concentrated cDNA was
ligated into a Lambda Triplex2 vector (CLONTECH), and the resulting
ligation reaction was packed using Gigapack gold III from Stratagene/
Biocrest (Cedar Creek, TN) following the manufacturer’s specifications.
The library obtained was plated by infecting log-phase XL1-blue cells
(CLONTECH), and the percentage of recombinants was determined by
PCR using vector primers flanking the inserted cDNA visualized on a
1.1% agarose gel with ethidium bromide (1.5 mg/ml).
Sequence of Isac—To isolate and sequence cDNA expressed by the
salivary glands of I. scapularis, we developed a protocol intended to
randomly match the cDNA to the amino terminus of the reverse-phase
HPLC-purified Isac. We plated the I. scapularis salivary gland cDNA
library at a density of ;200 plaques/plate (150-mm Petri dish). The
plaques were picked randomly and transferred to a 96-well polypro-
pylene plate containing 100 ml of water/well. The plate was covered and
placed on a gyrator shaker for 1 h at room temperature. Five ml of the
phage sample was used as a template for a PCR reaction to amplify
random cDNA. The primers for this reaction were sequences from the
triplEX2 vector, named PT2F1 (59-AAG TAC TCT AGC AAT TGT GAG
C-39), which is positioned upstream of the cDNA of interest (59-end), and
PT2R1 (59-CTC TTC GCT ATT ACG CCA GCT G-39), which is posi-
tioned downstream of the cDNA of interest (39-end). High fidelity plat-
inum Taq polymerase (Life Technologies, Inc.) was used for these reac-
tions. Amplification conditions were: 1 hold at 75 °C for 3 min, 1 hold at
94 °C for 3 min, and 34 cycles at 94 °C for 30 s, 49 °C for 30 s, and 72 °C
for 1 min 20 s. Amplified products were visualized on a 1.1% agarose gel
with ethidium bromide. The concentration of double strand cDNA was
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measured using Hoechst dye 33258 on a Flurolite 1000 plate fluorom-
eter (Dynatech Laboratories, Chantilly, VA). PCR reaction (3–4 ml)
containing between 100 and 200 ng of DNA were treated with exonu-
clease I (0.5 unit/ml) and shrimp alkaline phosphatase (0.1 unit/ml) for
15 min at 37 °C and 15 min at 80 °C on a 96-well PCR plate. This
mixture was used as a template for a cycle sequencing reaction using
the DTCS labeling kit from Beckman Coulter Inc. (Fullerton, CA). The
primer used for sequencing (PT2F3) is upstream of the inserted cDNA
and downstream of the primer PT2F1. The sequencing reaction was
performed in a Perkin-Elmer 9700 Thermalcycler. Conditions were
75 °C for 2 min, 94 °C for 4 min, and 30 cycles at 96 °C for 20 s, 50 °C
for 20 s, and 60 °C for 4 min. After cycle-sequencing the samples, a
cleaning step was done using the multiscreen 96-well plate-cleaning
system (Millipore); this plate was prepared by adding a fixed amount
(manufacturer’s specification) of Sephadex-50 (Amersham Pharmacia
Biotech) and 300 ml of deionized water. After 1 h of incubation at room
temperature, the water was removed from the multiscreen plate by
centrifugation at 750 3 g for 5 min. After partially drying the Sephadex
in the multiscreen plate, the whole cycle sequencing reaction was added
to the center of each well and centrifuged at 750 3 g for 5 min, and the
clean sample was collected on a sequencing microtiter plate (Beckman
Coulter, Inc.). The plate was dried using a SpeedVac SC 110 with a
microtiter plate holder (Savant Instruments Inc.). The dried samples
were immediately resuspended with 25 ml of deionized ultraPure form-
amide (J. T. Baker, Phillipsburg, NJ), and one drop of mineral oil was
added to the top of each sample. Samples were either sequenced imme-
diately on a CEQ 2000 DNA sequencing instrument (Beckman Coulter
Inc.) or stored at 230 °C.
Isolation of Isac and Construction of Expression Vector—We identi-
fied the cDNA with an open reading frame matching the amino termi-
nus of the reverse-phase HPLC-purified Isac. An aliquot (;100 ng) of
Isac PCR sample was reamplified using the PT2F1 and PT2R1 primers
(conditions as above, but only 25 PCR cycles), and the entire cDNA was
fully sequenced as described above on a CEQ 2000 using custom prim-
ers. Isac cDNA was cloned into a TOPO TA cloning vector (Invitrogen).
For expression of Isac, full-length cDNA was used as a template to
amplify only the cDNA fragment that began with the initial methionine
and ended at the first stop codon. The single product amplified was
immediately cloned into the eukaryotic cloning vector pcDNA3.1/
V5/His-TOPO (Invitrogen) following the manufacturer’s specifications.
The ligation mixture was used to transform TOP10 cells (Invitrogen),
and the cells were incubated overnight at 37 °C. Eight colonies were
selected and mixed with 10 ml of sterile water. Five ml of each sample
were transferred to Luria broth (LB) containing ampicillin (100 mg/ml)
and grown at 37 °C. The other 5 ml were used as a template for a PCR
reaction using two vector-specific primers from the pcDNA3.1/V5/
His-TOPO vector to confirm the presence of the insert and for sequenc-
ing analysis. After visualizing the PCR product on a 1.1% agarose gel,
we completely sequenced the eight PCR products as described above
with a CEQ2000 (Beckman Coulter Inc.). We chose two samples for
expression in this vector, one containing the complete sequence (from
methionine to stop codon) in the correct orientation of Isac (recombinant
Isac (r-Isac)) and a second containing the Isac complete sequence in
reverse orientation, which became our control (control Isac (c-Isac)).
Cells containing the sample and control were grown overnight at 37 °C
on LB with ampicillin (100 mg/ml), and plasmid isolation was performed
with the Wizard miniprep kit (Promega Corporation, Madison, WI).
After plasmid isolation, the sample and control plasmids were washed
three times with ultraPure water using an Amicon-100 (Millipore),
measured, and stored before attempting to transform COS-7 cells.
Expression of Isac in COS Cells—COS-7 cells (ATCC CRL 1651) were
cultivated in Dulbecco’s modified Eagle’s medium supplemented with 4
mM glutamine, antibiotics, and 10% heat-inactivated fetal calf serum
(complete medium) as described previously (21). Subconfluent COS-7
cells were transfected with Isac cDNA (r-Isac) or with the Isac in the
reverse orientation (c-Isac). Transfections were performed with the
Bio-Rad electroporation system using 200 V and 1000 millifarads in a
0.4-cm gap cuvette. DNA (200 and 400 mg) was used for each transfec-
tion at a cell density of 107/ml. After electroporation, the cells were
allowed to sit for 10 min at room temperature and then were placed into
10 ml of complete medium in a 75-cm2 culture flask at 37 °C/5% CO2.
After a 16-h incubation, the supernatants were collected, and 10 ml of
serum-free Dulbecco’s modified Eagle’s medium was added to the cul-
tures. This procedure was repeated daily up to 3 days after transfection.
The resultant supernatants were centrifuged at 10,000 3 g for 5 min,
concentrated 20-fold on Centricon Plus-20 (5-kDa cut-off) (Millipore
Corp.), and kept at 220 °C for bioassays. Control cells were transfected
FIG. 1. Molecular sieving chroma-
tography of homogenized I. scapu-
laris tick salivary glands. A, cumula-
tive UV (280 nm) absorbance tracings of
10 chromatograms representing 500 ho-
mogenized pairs of glands. Inset, log of Mr
standards plotted against their retention
times. The arrow indicates retention time
of the salivary anticomplement activity.
B, anticomplement activity was measured
in 12.5-ml aliquots of each fraction by
their ability to inhibit lysis of rabbit
erythrocytes by human serum in the pres-
ence of MgCl2.
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FIG. 2. Purification of I. scapularis
salivary anticomplement. A, UV ab-
sorbance at 220 nm from reverse-phase
chromatography using HCl as a modifier
from 1/3 of active fractions obtained from
the molecular sieving chromatography of
500 pairs of homogenized salivary glands
from I. scapularis. B, anticomplement ac-
tivity. C, reverse-phase chromatography
using HCl as a modifier, of the combined
active fractions obtained by reverse-phase
chromatography as in A. D, anticomple-
ment activity. E, reverse-phase chroma-
tography using trifluoroacetic acid as a
modifier of the active fractions obtained
by reverse-phase chromatography using
HCl as a modifier. F, anticomplement
activity.
FIG. 3. Nucleotide and predicted trans-
lated protein sequences from Isac cDNA
(A). The amino acids in bold were ob-
tained by Edman degradation (B). (S/G)
indicates equal signal of serine and gly-
cine, whereas X indicates that no amino
acid could be identified. This is Gen-
Bank™ accession number AF270496.
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with the Isac in the reverse orientation construct (c-Isac), and super-
natants were obtained as for the r-Isac-transfected cells.
Sequence Analysis—Sequence similarity searches were performed
using the Blast (22) program. Cleavage site predictions of the mature
proteins used the SignalP program (23).
RESULTS AND DISCUSSION
We initially attempted to purify I. scapularis salivary anti-
complement from a 550-ml sample of pilocarpine-induced tick
saliva. After one step of molecular sieving chromatography
followed by reverse-phase HPLC on a polymeric column using
a gradient of acetonitrile containing 8 mM HCl and a final step
on the same column using trifluoroacetic acid instead of HCl,
we obtained small amounts of a product with an amino-termi-
nal sequence (G)EDGLE, where (G) was a doubtful result.
Because of difficulties in collecting larger volumes of tick sa-
liva, a second effort was made to purify the protein from tick
salivary homogenates, which also possess anticomplement ac-
tivity as determined by its ability to inhibit lysis of rabbit
erythrocytes by human sera in the presence of Mg21/EGTA (not
shown). Accordingly, 500 pairs of salivary glands were homog-
enized in 50 ml of HEPES saline, and the supernatant (after 10
min at 10,000 3 g) was concentrated using a 10-kDa cut-off
Centricon (Millipore Corp.) filter. Ten aliquots of the concen-
trated homogenate were repeatedly injected into a molecular
sieving column, and the fractions were collected into the same
tubes at 0.4-min intervals. Two consecutive fractions were ac-
tive eluting with an apparent molecular mass of 62 kDa (Fig.
1).
These active fractions were combined, and acetonitrile and
HCl were added to give 10% organic solvent and 8 mM of the
acid. This fraction was further divided into three aliquots, each
injected into a reverse-phase polymeric resin eluted with a
gradient of acetonitrile in 8 mM HCl (Fig. 2A and B). Active
fractions from these three reverse-phase columns were com-
bined, diluted with water, and concentrated by passing over the
same column again with a gradient of acetonitrile HCl to yield
a single peak of UV-absorbing material (Fig. 2, C and D). These
fractions containing the UV-absorbing peak were combined
and injected into the same column and eluted with a gradient
of acetonitrile in 0.1% trifluoroacetic acid instead of HCl. Two
UV-absorbing peaks eluted, the second of which had anticom-
plement activity (Fig. 2, E and F). Fractions corresponding to
the active peak were concentrated by evaporation and then
sent for amino-terminal sequencing, which produced primary
sequence (S/G)EDGLEQDSKVEXXXQNLYE. This sequence
contained the shorter sequence obtained from HPLC purifica-
tion of the anticomplement from tick saliva.
Attempts to obtain a PCR product using primers based on
the above sequence failed, perhaps because of the high codon
FIG. 4. Inhibition of rabbit erythro-
cyte lysis by human serum in the
presence of different microliter
amounts (numbers) of COS cell super-
natants transfected with r-Isac or c-
Isac (Ctl). The plate reader was blanked
with wells containing 10 mM EDTA in-
stead of EGTA and MgCl2.
FIG. 5. Inhibition of C3b (A) and factor B (B) deposition to
agarose-coated plates by I. scapularis saliva and r-Isac-trans-
fected COS supernatants. Controls were run with supernatants of
COS cells transfected with the c-Isac cDNA sequence. Blanks were
obtained with wells incubated with 10 mM EDTA instead of EGTA and
MgCl2 during the complement activation step of the assay.
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degeneracy presented by the majority of amino acids found in
the sequence. A cDNA library from I. scapularis was randomly
sequenced, and 709 sequences were obtained. This library is
unidirectional with the cDNA being restricted with a rare
cutter restriction enzyme (SfiI) before ligation to the vector.
The probability of obtaining amino-terminal information from
the clones was enhanced by starting the cycle sequencing of the
library’s clones from the 59-region of the cDNA. In this manner,
a clone was found leading to the predicted Isac protein shown
in Fig. 3. The predicted protein has a putative signal peptide of
21 amino acids, the mature peptide having an amino-terminal
sequence in agreement with the measured sequence (Fig. 3).
The predicted mature peptide has 163 amino acids, a theoret-
ical pI of 4.48, and a Mr of 18,136.77, assuming that no carbox-
yl-terminal residue beyond the terminal proline is lost. No
significant similarities were found between Isac and any other
protein in the GenBankTM data base, when the blastx program
invoking the BLOSUM 62 matrix was used (22). The predicted
Isac sequence has seven Asn glycosylation sites, seven casein
kinase 2 phosphorylation sites, and three myristoilation sites,
as determined by scanning the Prosite data base.
To confirm that the cDNA sequence corresponded to an an-
ticomplement molecule, we expressed it in COS cells. Superna-
tants of cells transfected with r-Isac, but not those transfected
with c-Isac, had anticomplement activity as measured by their
ability to inhibit lysis of rabbit erythrocytes by human serum
(Fig. 4).
In the presence of Mg21 and serum, C3 is deposited co-
valently to agarose via the alternative complement pathway (1,
20). Serum fB binds noncovalently to agarose-bound C3b to
form the C3 convertase of the alternative pathway, creating
positive feedback for further C3 activation and deposition. This
assay is made specific to the alternative complement pathway
by the presence of EGTA, a Ca21 chelator, because calcium ions
are needed for classical and lectin-mediated complement acti-
vation (1). Based on these reactions, we developed a simple test
for identification of alternative pathway-dependent C3 deposi-
tion to agarose and fB association with C3b using agarose-
coated microwells. Using this test, tick saliva and r-Isac cells
prevented deposition of C3 to agarose-coated wells if added
together with serum to the incubation mixture (Fig. 5); how-
ever, if added 30 min after the addition of serum, C3 deposition
(which is a covalent phenomenon) cannot be displaced by sali-
va- or Isac-transformed COS cell supernatants, although fB,
which attaches noncovalently to C3b, is significantly displaced
by saliva or r-Isac.
To further compare the properties of r-Isac with the native
protein, we submitted r-Isac and tick saliva to chromatography
FIG. 6. Molecular sieving chroma-
tography of 50 ml of I. scapularis sa-
liva or 50 ml of concentrated superna-
tant of COS cells transfected with
r-Isac or with c-Isac. UV absorbance of
the chromatogram or inhibition of the ly-
sis of rabbit erythrocytes by human sera
in the presence of Mg21/EGTA is shown.
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on a TSK-2000 SW column. Both activities eluted with similar
retention time, although the recombinant protein eluted one
fraction earlier in the chromatogram (Fig. 6). The observed
retention times for both activities correspond to a molecular
mass of ;65 kDa, larger than the expected 18.5-kDa transla-
tion product deduced from Isac cDNA. This discrepancy may
reflect the anomalous behavior of some proteins in silica-based
molecular sieving columns known to have residual silanol
groups that may confer a cation exchange or anion exclusion
capability to the column or, alternatively, Isac may be post-
translationally modified by glycosylation and/or polymeriza-
tion. In either case, these results indicate the similarity in
chromatographic behavior of r-Isac and the native protein.
Because Isac could be a serine protease inhibitor, we meas-
ured its activity on the classical pathway of complement acti-
vation using sensitized sheep erythrocytes. We also determined
its effect on the recalcification time of citrated human plasma
in an assay that measures both the intrinsic and the common
pathway of the clotting cascade. Although I. scapularis saliva
inhibited blood clotting, no effect of saliva was found on the
classical pathway (triplicate experiment, using three saliva
samples). Purified c-Isac, as well as the supernatant of r-Isac-
transfected COS cells, did not have anticlotting or classical
anticomplement activity in concentrations that fully inhibited
the alternative complement pathway (not shown). These re-
sults indicate that Isac is different from the previously identi-
fied (but not molecularly characterized) unspecific antiprotease
activity found in whole body homogenates of the cattle tick,
Boophilus microplus (24).
Isac behaves as a regulator of complement activation in a
manner similar to decay accelerating factor and factor H, which
inhibit complement activation by interacting with the C3 con-
vertase of the classical or alternative pathway. Factor H is a
155-kDa glycoprotein containing 20 repetitive domains termed
short consensus repeats (25). In addition to its other effects on
the complement cascade, factor H inhibits interaction of factor
B with C3b (25), as does Isac. No significant sequence similar-
ity was found, however, between Isac and factor H or with any
other protein available in public domain data bases. Isac may
be structurally similar to single short consensus repeats, and
its four cysteines are consistent with the four cysteines con-
served in short consensus repeats of the factor H family (25). It
would thus appear that Isac belongs to a new class of comple-
ment regulatory molecules. Successful expression of this pro-
tein makes it a viable target for anti-tick vaccines.
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